![](/img/cover-not-exists.png)
Preclinical and Dose-Finding Phase 1 Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors
Davis, S. Lindsey, Ionkina, Anastasia A, Bagby, Stacey M., Orth, James D., Gittleman, Brian, Marcus, Joshua M., Lam, Elaine T, Corr, Bradley R., O'Bryant, Cindy L., Glode, Ashley E., Tan, Aik-Choon, KJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-19-3498
Date:
May, 2020
File:
PDF, 7.89 MB
2020